drug monitoring
Showing 9976 - 10000 of >10,000
Ocrelizumab in Breastmilk
Active, not recruiting
- Multiple Sclerosis
- Clinically Isolated Syndrome
-
San Francisco, CaliforniaUniversity of California, San Francisco
Mar 21, 2022
CARG, VES13, G8 Scales in Predicting Drug Toxicity in Patients
Recruiting
- Nivolumab Related Toxicity
- there is no intervention
-
Tekirdağ, TurkeyTekirdağ Namık Kemal University
Oct 2, 2022
Cardiac Surgery, Hypertension, Pulmonary Trial in Jinan (Pituitrin, normal saline)
Not yet recruiting
- Cardiac Surgery
- Hypertension, Pulmonary
- Pituitrin
- normal saline
-
Jinan, Shandong, ChinaQianfoshan Hospital, The First Hospital affiliated of Shandong F
Feb 5, 2023
Peripheral Artery Disease Trial in Austria, Germany (Percutaneous Transluminal Angioplasty (PTA) MagicTouch Sirolimus Coated PTA
Recruiting
- Peripheral Artery Disease
- Percutaneous Transluminal Angioplasty (PTA) MagicTouch Sirolimus Coated PTA Balloon Catheter
- Percutaneous Transluminal Angioplasty (PTA) with non-coated balloon catheter (POBA)
-
Wien, Austria
- +18 more
Apr 5, 2022
Alcohol Use Disorder (AUD), Alcoholism Trial in Philadelphia (Ibudilast, Medical management, Placebo)
Recruiting
- Alcohol Use Disorder (AUD)
- Alcoholism
- Ibudilast
- +2 more
-
Philadelphia, PennsylvaniaUniversity of Pennsylvania Center for Studies of Addiction
Jan 17, 2023
Feasibility of Visual Field Screening Apps
Recruiting
- Visual Field Defect, Peripheral
- iPad-Based Visual Field Test
-
Southampton, United KingdomEye Unit, University Hospitals Southampton NHS Foundation Trust
Dec 9, 2021
Nausea, Vomiting Trial in El Paso (Inhaled Isopropyl Alcohol (IPA), Oral Dissolvable Tablet Zofran (ondansetron))
Recruiting
- Nausea
- Vomiting
- Inhaled Isopropyl Alcohol (IPA)
- Oral Dissolvable Tablet Zofran (ondansetron)
-
El Paso, Texas
- +1 more
Apr 5, 2022
Soft-tissue Sarcoma Trial in London (Compound 451238)
Active, not recruiting
- Soft-tissue Sarcoma
- Compound 451238
-
London, United KingdomThe Royal Marsden NHS Foundation Trust
Dec 14, 2021
Blood Based Response Monitoring of B-cell Lymphoma Patients
Active, not recruiting
- NHL
- No intervention
-
Alkmaar, Netherlands
- +59 more
Mar 22, 2022
Pharmacokinetics, Pharmacodynamics Trial in Moenchengladbach (laquinimod, Placebo)
Completed
- Pharmacokinetics
- Pharmacodynamics
- laquinimod
- Placebo
-
Moenchengladbach, GermanyTeva Investigational Site 32415
Nov 5, 2021
Coronary Disease Trial in Cadiz (Mobile application)
Recruiting
- Coronary Disease
- Mobile application
-
Cadiz, SpainHospital Puerta del Mar
May 17, 2022
Hypoxia Trial in Mainz (ORI measurement by Radical 97)
Completed
- Hypoxia
- ORI measurement by Radical 97
-
Mainz, GermanyJohannes Gutenbert University Centre
Sep 2, 2021
Trachoma Trial in Addis Ababa (behavioral, drug, other)
Recruiting
- Trachoma
- Water, sanitation, and hygiene (WASH) intervention
- +4 more
-
Addis Ababa, EthiopiaThe Carter Center Ethiopia
Jun 24, 2021
Diabetes, Type 2 Trial in Neuss (LY3532226, Placebo, Dulaglutide)
Recruiting
- Diabetes Mellitus, Type 2
- LY3532226
- +2 more
-
Neuss, GermanyProfil Institut für Stoffwechselforschung
Jun 30, 2022
Axial Spondyloarthritis Trial in Saint Petersburg (anti-TRBV9 mAb, low dose, anti-TRBV9 mAb, high dose, )
Recruiting
- Axial Spondyloarthritis
- anti-TRBV9 monoclonal antibody, low dose
- +2 more
-
Saint Petersburg, Russian Federation
- +1 more
Jun 30, 2022
STEMI, Primary PCI Trial in Wuhan (Heparin Sodium Injection)
Recruiting
- STEMI
- Primary PCI
- Heparin Sodium Injection
-
Wuhan, Hubei, ChinaRenmin Hospital of Wuhan university
Jul 29, 2022
Advanced Solid Tumor Trial in Shanghai (LM-302 Injection)
Recruiting
- Advanced Solid Tumor
- LM-302 Injection
-
Shanghai, Shanghai, ChinaShanghai East Hospital
Dec 29, 2021
Lung Carcinoma, Metastatic Malignant Tumor in the Lung, Stage IV Lung Cancer AJCC v8 Trial in Palo Alto (procedure, drug, other)
Active, not recruiting
- Lung Carcinoma
- +4 more
- Near-Infrared Fluorescence Imaging
- +3 more
-
Palo Alto, CaliforniaStanford University, School of Medicine
Jun 21, 2022
Patients With Advanced Solid Tumors Trial in Beijing (human single chain IL-12 mRNA-single dose, human single chain IL-12
Recruiting
- Patients With Advanced Solid Tumors
- human single chain IL-12 mRNA-single dose
- human single chain IL-12 mRNA-multiple dose
-
Beijing, ChinaCancer Institute and Hospital, Chinese Academy of Medical Scienc
Jun 19, 2022
HER2-positive Breast Cancer, Operable Breast Cancer Trial in France (Trastuzumab + Paclitaxel, Pegfilgrastim)
Recruiting
- HER2-positive Breast Cancer
- Operable Breast Cancer
- Trastuzumab + Paclitaxel
- Pegfilgrastim
-
Avignon, France
- +8 more
Jan 9, 2023
Study of New Magnetic Resonance Imaging Methods of the Brain
Recruiting
- Healthy
- +4 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Feb 2, 2023